Get App Open
In App
News on WhatsApp
News on WhatsApp
Open App

ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Growth

  • Regular
  • Direct
Category : Sectoral/Thematic
  • NAV
    : ₹ 39.95 0.68%
    (as on 02nd January, 2026)
Crisil Rating

Not Rated

Rank not available for the fund
Risk-O-Meter
Very High Risk

The fund has 97.7% investment in domestic equities of which 40.05% is in Large Cap stocks, 15.9% is in Mid Cap stocks, 9.01% in Small Cap stocks.

Suitable For : Investors who have advanced knowledge of macro trends and prefer to take selective bets for higher returns compared to other Equity funds. At the same time, these investors should also be ready for possibility of moderate to high losses in their investments even though overall market is performing better.

This Scheme
VS
  • Benchmark
    BSE Healthcare TRI
  • NA
  • NA
  • Gold
Compare with
  • Date : -
  • NAV : -
  • Date : -
  • Investment : -
  • Value on selected date : -
  • Returns Calculator
  • SIP Calculator
  • VIP (Value Avg)
Amount
  • Investment Date
  • Sell Date
  • Investment Value
    -
  • Sell Value
    -
  • Profit/Loss
    -
  • Annualised Returns
    -
  • Date : -
  • Investment : -
  • Value on selected date : -

Returns (NAV as on 02nd January, 2026)

Period Invested for ₹10000 Invested on Latest Value Absolute Returns Annualised Returns Category Avg Rank within Category
1 Week 26-Dec-25 10035.20 0.35% - 1.24% 207/256
1 Month 02-Dec-25 9925.50 -0.74% - 0.72% 212/253
3 Month 01-Oct-25 10137.00 1.37% - 3.62% 181/245
6 Month 02-Jul-25 10088.40 0.88% - 2.77% 157/234
YTD 01-Jan-26 10068.00 0.68% - 0.93% 201/244
1 Year 02-Jan-25 9891.10 -1.09% -1.09% 3.51% 146/219
2 Year 02-Jan-24 14370.50 43.70% 19.85% 13.24% 11/166
3 Year 02-Jan-23 20894.40 108.94% 27.81% 19.10% 8/137
5 Year 01-Jan-21 22431.20 124.31% 17.52% 18.28% 54/116
Since Inception 13-Jul-18 39950.00 299.50% 20.34% 12.29% 22/220

SIP Returns (NAV as on 02nd January, 2026)

Period Invested for ₹1000 SIP Started on Investments Latest Value Absolute Returns Annualised Returns
1 Year 02-Jan-25 12000 12459.96 3.83 % 7.14 %
2 Year 02-Jan-24 24000 27008.53 12.54 % 11.77 %
3 Year 02-Jan-23 36000 49673.31 37.98 % 22.02 %
5 Year 01-Jan-21 60000 99119.17 65.2 % 20.15 %
 

Tax Treatment

If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.

Portfolio (Updated on 30th Nov,2025)

Portfolio Turnover Ratio : 60.00%  |   Category average turnover ratio is 167.64%  
Fund manager updated portfolio less frequently than peers in last 1 year. (I.e. fund manager held stocks/bonds in the portfolio for longer duration than peers)
Equity Holding : 97.70% | F&O Holdings : 0.00%| Foreign Equity Holdings : 0.00%| Total : 97.70%
No of Stocks : 38 (Category Avg - 44.43) | Large Cap Investments : 40.05%| Mid Cap Investments : 15.9% | Small Cap Investments : 9.01% | Other : 32.75%

Top 10 Stocks in Portfolio

How to read this table?
Stock Invested in Sector Value(Mn) % of Total Holdings 1M Change 1Y Highest Holding 1Y Lowest Holding Quantity 1M Change in Qty
Sun Pharmaceutical Industries Ltd. Pharmaceuticals 8285.4 12.83% 0.95% 13.83% (Dec 2024) 11.58% (Sep 2025) 45.24 L 0.00
Dr. Reddys Laboratories Ltd. Pharmaceuticals 6340.2 9.81% 0.39% 9.81% (Nov 2025) 8.28% (Jan 2025) 50.37 L -0.28 L
Cipla Ltd. Pharmaceuticals 5166.7 8.00% 1.39% 9.71% (Jan 2025) 6.61% (Oct 2025) 33.74 L 5.40 L
Divis Laboratories Ltd. Pharmaceuticals 4829.8 7.48% -1.03% 9.23% (Aug 2025) 5.56% (Dec 2024) 7.46 L -0.67 L
Aurobindo Pharma Ltd. Pharmaceuticals 3901.5 6.04% -1.58% 8.25% (Sep 2025) 4.87% (Jan 2025) 31.81 L -0.11 Cr
Lupin Ltd. Pharmaceuticals 3684.7 5.70% 0.31% 5.7% (Nov 2025) 3.79% (Jun 2025) 17.70 L 0.00
Mankind Pharma Ltd. Pharmaceuticals 3252.7 5.04% 2.25% 5.04% (Nov 2025) 1.62% (May 2025) 14.45 L 6.92 L
Alkem Laboratories Ltd. Pharmaceuticals 2440.6 3.78% -0.20% 4.49% (Feb 2025) 3.78% (Nov 2025) 4.29 L -0.36 L
Syngene International Ltd. Healthcare research, analytics & technology 1916.5 2.97% 0.74% 2.97% (Nov 2025) 1.52% (Jan 2025) 29.56 L 7.50 L
Suven Pharmaceuticals Ltd. Pharmaceuticals 1731.6 2.68% 0.60% 2.68% (Nov 2025) 0% (Dec 2024) 30.68 L 12.87 L
- indicates change in weight in the portfolio. # indicates a new entry.
Name Type of Instrument Weight (%)
TREPS TREPS 2.23%
Margin Margin 0.13%
Net Receivables Net Receivables -0.06%

Risk Ratios

Ratios calculated on daily returns for last 3 years (Updated as on 31st December, 2025)

  • Standard Deviation

    Low volatility
    11.53vs12.38
    Category Avg
  • Beta

    High volatility
    0.9vs0.86
    Category Avg
  • Sharpe Ratio

    Better risk adjusted returns
    1.68vs1.02
    Category Avg
  • Treynor's Ratio

    Better risk adjusted returns
    0.21vs0.17
    Category Avg
  • Jensen's Alpha

    Better risk adjusted returns
    4.44vs3.03
    Category Avg

Alternative Funds (Category Peers)

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
Nippon India Taiwan Equity Fund - Regular Plan - Growth NA 423.45 4.27 9.61 35.03 54.54 38.85
Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth NA 273.54 1.18 3.00 13.86 35.03 16.49
Franklin Asian Equity Fund - Growth NA 297.29 2.39 5.61 15.70 23.99 12.59
Quant BFSI Fund - Regular Plan - Growth NA 728.97 3.60 9.49 12.69 22.72 0.00
DSP Banking & Financial Services Fund - Regular Plan - Growth NA 1582.52 2.46 8.00 7.13 20.00 0.00
Nippon India Japan Equity Fund - Growth NA 289.88 0.77 2.14 10.70 19.76 15.82
SBI Banking & Financial Services Fund - Regular Plan - Growth NA 9812.64 1.53 7.56 7.31 19.35 19.56
SBI Automotive Opportunities Fund - Regular Plan - Growth NA 5379.86 3.54 8.73 18.17 19.32 0.00
HDFC Transportation and Logistics Fund - Regular Plan - Growth NA 1747.87 0.61 2.41 14.05 19.31 0.00
ITI Banking and Financial Services Fund - Regular Plan - Growth NA 348.01 1.19 9.12 7.19 19.14 13.96

More Funds from ICICI Prudential Mutual Fund

Out of 175 mutual fund schemes offered by this AMC, 10 is/are ranked 5 * , 8 is/are ranked 4 * , 15 is/are ranked 3 * , 5 is/are ranked 2 * , 2 is/are ranked 1 * , and 135 schemes are not ranked. See more about AMC

Scheme Name
Crisil Rank
Asset Size (Cr)
1M
3M
6M
1Y
3Y
ICICI Prudential Large Cap Fund - Growth 5 78159.80 -0.28 4.84 3.68 10.99 18.38
ICICI Prudential Multi-Asset Fund - Growth 3 75067.36 0.95 5.20 7.79 18.20 19.55
ICICI Prudential Multi-Asset Fund - Growth 3 75067.36 0.00 0.00 0.00 0.00 0.00
ICICI Prudential Balanced Advantage Fund - Growth 2 69867.93 0.39 3.69 4.89 12.17 13.71
ICICI Prudential Value Fund - Growth 5 60390.59 -0.07 5.55 4.94 13.05 21.34
ICICI Prudential Equity & Debt Fund - Growth 5 49222.51 -0.29 3.13 4.43 12.92 19.41
ICICI Prudential Liquid Fund - Growth 3 47726.07 0.50 1.45 2.89 6.47 6.93
ICICI Prudential Nifty 50 ETF 5 36387.62 -0.11 5.42 2.88 11.46 14.26
ICICI Prudential Nifty 50 ETF 5 36387.62 -0.11 5.42 2.88 11.46 14.26
ICICI Prudential Money Market Fund - Growth 4 36028.87 0.49 1.48 2.98 7.42 7.50
Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347